BrightHeart

BrightHeart

Private
ParisHealthcare & Life Scienceshttps://brightheart.ai

Last Round

Series A

Jan 8, 2026

Total Funding Raised

$14.98M

Company Overview

BrightHeart is a medical technology company that has developed an AI-powered software platform for prenatal ultrasound to improve the detection of fetal congenital heart defects.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

prenatal ultrasound AIfetal heart screeningcongenital heart defectsCHDsmedical imaging AIcomputer-aided diagnosisCAD softwareclinical decision supportfetal ultrasound softwareAI medical deviceultrasound workflow integrationmaternal-fetal medicineMFMAI in obstetricsFDA 510(k) clearance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BrightHeart Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BrightHeart Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJan 8, 2026
SeedMay 31, 2023

BrightHeart Investors

Notable investors and investment history

InvestorRounds
Odyssée VentureSeries A
Lift ValueSeries A
GO CapitalSeries A
Mussallem CHD AllianceSeries A
Sofinnova PartnersSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    B-Right AI Platform for prenatal ultrasound is now generally available.

  • Feb 1, 2026

    Partnered with GE HealthCare to integrate AI into prenatal care.

BrightHeart Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BrightHeart Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BrightHeart's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Year Founded2022
Last FundingJan 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.